CDC rolls out the 2022 Clinical Practice Guideline for Prescribing Opioids for Pain

New guideline provides evidence-based recommendations to help patients and clinicians make informed, patient-centered decisions about effective pain care.

Pain is one of the most common reasons adults seek medical care here in the United States. All patients with pain should receive safe, effective, and informed pain care options. CDC has released a new guideline to support patients and clinicians in reaching their goals for pain care and function.

CDC’s 2022 Clinical Practice Guideline for Prescribing Opioids for Pain, which updates and replaces the 2016 CDC Guideline, is a clinical tool to improve communication between clinicians and patients and empower them to make collaborative, individualized, and informed decisions related to pain care. It provides 12 voluntary recommendations for clinicians providing pain care and includes expanded guidance for treatment of acute and subacute pain. The 2022 Clinical Practice Guideline incorporates new evidence to help primary care and other clinicians weigh the risks and benefits of a full range of pain treatment options, including prescription opioids.

The release of the 2022 Clinical Practice Guideline is an important step towards promoting safe and effective pain care. Share and promote the 2022 Clinical Practice Guideline and related resources:

Additional Overdose and Opioid Resources
Share this post: